Search Results - "HERDER, G. J"

Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission by de Laat, B, Traets, M J M, De Laat-Kremers, R W M, Verweij, S P, Ninivaggi, M, Jong, E, Huskens, D, Blok, B A, Remme, G C P, Miszta, A, Nijhuis, R H T, Herder, G J M, Fijnheer, R, Roest, M, Fiolet, A T L, Remijn, J A

“…Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombosis. We conducted a…”
Get full text

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach by Hubers, A J, Heideman, D A M, Burgers, S A, Herder, G J M, Sterk, P J, Rhodius, R J, Smit, H J, Krouwels, F, Welling, A, Witte, B I, Duin, S, Koning, R, Comans, E F I, Steenbergen, R D M, Postmus, P E, Meijer, G A, Snijders, P J F, Smit, E F, Thunnissen, E

“…Background: Lung cancer has the highest mortality of all cancers. The aim of this study was to examine DNA hypermethylation in sputum and validate its…”
Get full text

What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?—Results from the lung cancer economics and outcomes research (LUCEOR) study by Lester, J.F, Agulnik, J, Akerborg, O, Chouaid, C, De Geer, A, Finnern, H.W, Herder, G.J.M, Lungershausen, J, Mitchell, P.L.R, Vansteenkiste, J, Ziske, C, Goker, E

“…Abstract Background A significant proportion of advanced non-small cell lung cancer (NSCLC) patients receive supportive treatments to manage disease-related…”
Get full text

Two malignancies or an unusual presentation of a pleural malignancy? by Knipscheer, B.J, Kromontono, R.C.R, de Bruin, P.C, van Strijen, M.J.L, Herder, G.J.M

“…Abstract Malignant mesothelioma is primarily located in the pleura. Progression usually involves adjacent tissue invasion. Both lymphatic and haematogenous…”
Get full text

Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department by Nijhuis, R.H.T., Russcher, A., de Jong, G.J., Jong, E., Herder, G.J.M., Remijn, J.A., Verweij, S.P.

“…•The prevalence of SARS-CoV-2 in blood from patients with COVID-19 was determined.•SARS-CoV-2 was found in 5.9 % of the tested patients.•Plasma should not be…”
Get full text

In search of an unknown primary tumour presenting with extracervical metastases: the diagnostic performance of FDG-PET by JOSHI, U, VAN DER HOEVEN, J. J. M, COMANS, E. F. I, HERDER, G. J, TEULE, G. J. J, HOEKSTRA, O. S

“…A retrospective study was carried out to determine the performance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unknown…”
Get full text

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170) by Dingemans, A.-M. C., Groen, H.J.M., Herder, G.J.M., Stigt, J.A., Smit, E.F., Bahce, I., Burgers, J.A., van den Borne, B.E.E.M., Biesma, B., Vincent, A., van der Noort, V., Aerts, J.G.

“…Nitroglycerin (NTG) increases tumor blood flow and oxygenation by inhibiting hypoxia-inducible-factor (HIF)-1. A randomized phase II study has shown improved…”
Get full text

Pulmonary artery aneurysms and thrombi by Steendam, C M J, Diederik, A L, Dendooven, A, Snijder, R J, Herder, G J

Get more information

Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer by Herder, G J, van Tinteren, H, Comans, E F, Hoekstra, O S, Teule, G J, Postmus, P E, Joshi, U, Smit, E F

“…Background: A study was undertaken to study the effect of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the diagnosis and management of…”
Get full text

Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals by Herder, G J M, Verboom, P, Smit, E F, van Velthoven, P C M, van den Bergh, J H A M, Colder, C D, van Mansom, I, van Mourik, J C, Postmus, P E, Teule, G J J, Hoekstra, O S

“…Background: A study was undertaken to investigate the clinical practice, yield, and costs of preoperative staging in patients with suspected NSCLC and to…”
Get full text

68GaGa-FAPI-46 PET/CT as an early indicator of complete remission in a patient treated with pembrolizumab for stage IV NSCLC by Borgonje, P E, Andrews, L M, van den Brand, J J G, Herder, G J M, de Klerk, J M H

Get full text

[68Ga]Ga-FAPI-46 PET/CT as an early indicator of complete remission in a patient treated with pembrolizumab for stage IV NSCLC by Borgonje, P. E., Andrews, L. M., van den Brand, J. J. G., Herder, G. J. M., de Klerk, J. M. H.

Get full text

Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial by Billingy, Nicole E, Tromp, Vashti N M F, Aaronson, Neil K, Hoek, Rianne J A, Bogaard, Harm Jan, Onwuteaka-Philipsen, Bregje D, van de Poll-Franse, Lonneke, Hugtenburg, Jacqueline G, Belderbos, José, Becker-Commissaris, Annemarie, van den Hurk, Corina J G, Walraven, Iris

“…Previous studies using patient-reported outcomes measures (PROMs) to monitor symptoms during and after (lung) cancer treatment used alerts that were sent to…”
Get full text

A Randomized Controlled Trial comparing Indwelling Pleural Catheters with Talc Pleurodesis (NVALT-14) by Boshuizen, R.C, vd Noort, V, Burgers, J.A, Herder, G.J.M, Hashemi, S.M.S, Hiltermann, T.J.N, Kunst, P.W, Stigt, J.A, van den Heuvel, M.M

“…Highlights • Indwelling pleural catheter and talc pleurodesis are both effective treatments for recurrent malignant pleural effusion. • No difference was…”
Get full text

A patient with fatigue and subfebrile temperature by Herder, G.J.m, Smit, E.f, Borgstein, P.j, Postmus, P.e

Get full text

Traditional versus up-front 18FDG PET staging of non-small cell lung cancer (NSCLC): A Dutch Co-operative randomized study by Herder, G. J.

“…Abstract only…”
Get full text

Traditional versus up-front 18FDG PET staging of non-small cell lung cancer (NSCLC): A Dutch Co-operative randomized study by Herder, G. J.

“…Abstract only…”
Get full text

New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis by Lind, J S W, Herder, G J M, Smit, E F

“…The recently developed 'targeted' therapies, epidermal growth factor receptor (EGFR) inhibitors and angiogenesis inhibitors, target specific tumour…”
Get more information

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases by Herder, Gjm, Codrington, H, Colder, C D, Aerts, J G

“…Previous research showed that the addition of bevacizumab (a monoclonal antibody against vascular endothelial growth factor [VEGF]) to chemotherapy resulted in…”
Get full text

Positron emission tomography scans can detect radiographically occult lung cancer in the central airways by Herder, G J, Breuer, R H, Comans, E F, Risse, E K, van Mourik, J C, Postmus, P E, Sutedja, T G

Get full text